The summer of 2022 has witnessed a number of significant developments in the pharmaceuticals and healthcare sector in Turkey. The Turkish Medicine and Medical Devices Authority (“Authority”) has issued guidelines and announcements with a view to aligning with the international standards and addressing the
commonly encountered procedural issues.
You can reach full of the briefing here.
Share
Related persons
You can contact us for detailed information.
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
20 December 2024
Amendments to Turkish Sustainability Reporting Standarts
The decision of the Public Oversight, Accounting, and Auditing Standards Authority (the “Decision”) on determining the scope of application…
12 December 2024
Recent Developments in Healthcare Legislation – 2024 Fall Issue
On 28 May 2024, Turkish Medicines and Medical Devices Agency (“Agency”) has shared the Draft Regulation on the Promotional Activities of…
29 November 2024
Turkish Competition Law Newsletter – 2024 Autumn Issue
The first decision involved Trugo Akıllı Şarj Çözümleri Sanayi ve Ticaret A.Ş. (“Trugo”), a subsidiary of Türkiye’nin Otomobili Girişim…
15 November 2024
WPP YEKA Tender 2024
The Republic of Türkiye’s Ministry of Energy and Natural Resources (“Ministry”) announced the Tender for the Allocation of Renewable…
25 October 2024
Regulation on the Withdrawal of Human Medicinal Products and Foods for Special Medical Purposes
The Regulation introduces provisions regulating withdrawal processes in a specific and detailed way and aligning such processes with modern…